aspirin has been researched along with Cardiac Remodeling, Ventricular in 11 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We assessed the effects of ticagrelor, aspirin and prasugrel, started 7days after myocardial ischemia-reperfusion injury on remodeling, inflammation and fibrosis in the rat." | 7.91 | Ticagrelor Improves Remodeling, Reduces Apoptosis, Inflammation and Fibrosis and Increases the Number of Progenitor Stem Cells After Myocardial Infarction in a Rat Model of Ischemia Reperfusion. ( Birnbaum, Y; Chen, H; Nylander, S; Sampaio, LC; Tran, D; Ye, Y, 2019) |
| "Continuous aspirin treatment (120 mg/kg/d) reduces the expression of proinflammatory cytokines after myocardial infarction, but does not affect post-infarct cardiac remodeling and cardiac function." | 7.74 | High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction. ( Adamek, A; Bauersachs, J; Bayer, B; Ertl, G; Frantz, S; Hu, K; Wagner, H, 2007) |
| "193 patients with their first non-Q-wave myocardial infarction (NQMI) were examined with the aim of studying the functional features of NQMI and estimate the influence of pre-hospital treatment with propranalol (PP), heparin and aspirin." | 7.73 | [Functional features of acute non-Q-wave myocardial infarction and the influence of pre-hospital treatment with propranalol, heparin and aspirin on the prognosis of the disease]. ( Baltabaev, TB; Beĭshenkulov, MT; Kudaĭbergenova, NT, 2005) |
| " A total of 154 untreated hypertensive patients, aged 40 to 66 years, with World Health Organization stage I or II hypertension and left ventricular hypertrophy, were randomized to receive placebo, candesartan (32 mg), each of these plus aspirin (300 mg/d), or the same preparations in a reverse order, for 3 weeks, with a 3-week washout period between treatments." | 5.14 | Candesartan improves maximal exercise capacity in hypertensives: results of a randomized placebo-controlled crossover trial. ( Chiariello, M; De Rosa, ML, 2009) |
| "We assessed the effects of ticagrelor, aspirin and prasugrel, started 7days after myocardial ischemia-reperfusion injury on remodeling, inflammation and fibrosis in the rat." | 3.91 | Ticagrelor Improves Remodeling, Reduces Apoptosis, Inflammation and Fibrosis and Increases the Number of Progenitor Stem Cells After Myocardial Infarction in a Rat Model of Ischemia Reperfusion. ( Birnbaum, Y; Chen, H; Nylander, S; Sampaio, LC; Tran, D; Ye, Y, 2019) |
| "The objective of this study is to investigate the interaction of Panax quinquefolius saponin (PQS) and dual antiplatelets (aspirin and clopidogrel) on antiplatelet activity and vascular endothelial function in rats with acute myocardial infarction (AMI)." | 3.81 | Interaction of Panax quinquefolius Saponin and Dual Antiplatelets on Vascular Endothelial Function in Rats with Acute Myocardial Infarction. ( Liu, J; Liu, Y; Shang, Q; Shi, D; Wang, B; Zhang, L; Zhang, Q, 2015) |
| "Continuous aspirin treatment (120 mg/kg/d) reduces the expression of proinflammatory cytokines after myocardial infarction, but does not affect post-infarct cardiac remodeling and cardiac function." | 3.74 | High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction. ( Adamek, A; Bauersachs, J; Bayer, B; Ertl, G; Frantz, S; Hu, K; Wagner, H, 2007) |
| "193 patients with their first non-Q-wave myocardial infarction (NQMI) were examined with the aim of studying the functional features of NQMI and estimate the influence of pre-hospital treatment with propranalol (PP), heparin and aspirin." | 3.73 | [Functional features of acute non-Q-wave myocardial infarction and the influence of pre-hospital treatment with propranalol, heparin and aspirin on the prognosis of the disease]. ( Baltabaev, TB; Beĭshenkulov, MT; Kudaĭbergenova, NT, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birnbaum, Y | 1 |
| Tran, D | 1 |
| Chen, H | 1 |
| Nylander, S | 1 |
| Sampaio, LC | 1 |
| Ye, Y | 1 |
| Agmadova, ZM | 1 |
| Kallaeva, AN | 1 |
| Wang, B | 1 |
| Liu, Y | 1 |
| Shang, Q | 1 |
| Zhang, Q | 1 |
| Zhang, L | 1 |
| Liu, J | 1 |
| Shi, D | 1 |
| Park, Y | 1 |
| Tantry, US | 1 |
| Koh, JS | 1 |
| Ahn, JH | 1 |
| Kang, MG | 1 |
| Kim, KH | 1 |
| Jang, JY | 1 |
| Park, HW | 1 |
| Park, JR | 1 |
| Hwang, SJ | 1 |
| Park, KS | 1 |
| Kwak, CH | 1 |
| Hwang, JY | 1 |
| Gurbel, PA | 1 |
| Jeong, YH | 1 |
| Rakowski, T | 1 |
| Mielecki, W | 1 |
| Brzozowska-Czarnek, A | 1 |
| Dziewierz, A | 1 |
| Siudak, Z | 1 |
| Legutko, J | 1 |
| Rzeszutko, L | 1 |
| Urbanik, A | 1 |
| Dubiel, JS | 1 |
| Dudek, D | 1 |
| De Rosa, ML | 1 |
| Chiariello, M | 1 |
| Tereshchenko, SN | 1 |
| Aleksandriia, LG | 1 |
| Moiseev, VS | 1 |
| Beĭshenkulov, MT | 1 |
| Kudaĭbergenova, NT | 1 |
| Baltabaev, TB | 1 |
| van Albada, ME | 1 |
| Berger, RM | 1 |
| Niggebrugge, M | 1 |
| van Veghel, R | 1 |
| Cromme-Dijkhuis, AH | 1 |
| Schoemaker, RG | 2 |
| Adamek, A | 1 |
| Hu, K | 1 |
| Bayer, B | 1 |
| Wagner, H | 1 |
| Ertl, G | 1 |
| Bauersachs, J | 1 |
| Frantz, S | 1 |
| Van Kerckhoven, R | 1 |
| Kalkman, EA | 1 |
| Saxena, PR | 1 |
3 trials available for aspirin and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effects of early abciximab administration before primary percutaneous coronary intervention on left ventricular function assessed by cardiac magnetic resonance.
Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Anticoagulants; Aspirin; Female; Follow-Up Studies; | 2008 |
Candesartan improves maximal exercise capacity in hypertensives: results of a randomized placebo-controlled crossover trial.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Aspirin; Benzimidazol | 2009 |
[Use of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Diur | 2002 |
8 other studies available for aspirin and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Ticagrelor Improves Remodeling, Reduces Apoptosis, Inflammation and Fibrosis and Increases the Number of Progenitor Stem Cells After Myocardial Infarction in a Rat Model of Ischemia Reperfusion.
Topics: Animals; Apoptosis; Aspirin; Atrial Natriuretic Factor; Disease Models, Animal; Drug Therapy, Combin | 2019 |
[Special characteristics of progression of myocardial remodeling in patients with various forms of unstable angina].
Topics: Aged; Angina, Unstable; Aspirin; Benzopyrans; Cardiovascular Agents; Disease Progression; Drug Thera | 2014 |
Interaction of Panax quinquefolius Saponin and Dual Antiplatelets on Vascular Endothelial Function in Rats with Acute Myocardial Infarction.
Topics: Animals; Aspirin; Clopidogrel; Coronary Vessels; Endothelial Cells; Humans; Male; Myocardial Infarct | 2015 |
Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
Topics: Aged; Aspirin; Biomarkers; Blood Platelets; C-Reactive Protein; Chi-Square Distribution; Clopidogrel | 2017 |
[Functional features of acute non-Q-wave myocardial infarction and the influence of pre-hospital treatment with propranalol, heparin and aspirin on the prognosis of the disease].
Topics: Adrenergic beta-Antagonists; Adult; Anticoagulants; Aspirin; Data Interpretation, Statistical; Elect | 2005 |
Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.
Topics: Animals; Arachidonic Acid; Aspirin; Blood Pressure; Capillaries; Disease Models, Animal; Echocardiog | 2006 |
High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Collagen; Coronary Vessels; Disease Model | 2007 |
Altered cardiac collagen and associated changes in diastolic function of infarcted rat hearts.
Topics: Adrenergic beta-Agonists; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal | 2000 |